Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The Italy point-of-care glucose testing market has been witnessing significant growth during the forecast period, owing to increase in investments in healthcare infrastructure and rise in awareness for diabetes treatment. Moreover, technological advancements are driving the market growth.
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.
The Point of care diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 816.12 million by 2028. Increasing prevalence of chronic diseases and rising preference for homecare testing are anticipated to drive the growth of the market.
Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027
Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report
Bright Star Care® as a family business in 2002 to provide the full continuum of home care, (including adult and elder care) child care (including newborn care, babysitter and nanny services) in addition to medical staffing services for individuals, families and healthcare facilities
Bright Star Care® as a family business in 2002 to provide the full continuum of home care, (including adult and elder care) child care (including newborn care, babysitter and nanny services) in addition to medical staffing services for individuals, families and healthcare facilities
Prize for TB low-cost point of care rapid diagnostic test. Pierre Chirac ... In order to claim the Grand Prix, the. winner would have to grant licenses to all patent ...
Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The report offers insightful and detailed information regarding key players operating in the Point of Care Testing for Infectious Diseases Market & their future strategies.
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
This 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Read more: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-point-of-care-poc-lipid-testing-supplier-shares-and-country-forecasts-market
The France point-of-care glucose testing market is expected to witness strong growth during the forecast period due to increase in demand for glucose testing from consumers and healthcare providers. The market is segmented into product type, application, and end user.
Global Coronavirus Test Kits Market, By Test Type (Molecular Testing and Serological Testing), Sample Type (Swab Test, Nasal Aspirate, Tracheal Aspirate, Blood Test and Sputum Test), End-User (Hospitals, Point of Care Testing, Reference Laboratories and Home Care) – Industry Trends and Forecast to 2029
The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.
Blockchain applications demand standard testing such as functional performance, integration, and security testing. In addition, testing teams must have these specialized testing capabilities including Smart Contracts testing and Node Testing. know how differently each industry is influencing Blockchain Testing capabilities.
The global point of care diagnostics market was valued at US$ 17,886.3 Mn 2018 and is expected to reach US$ 30,175.3 Mn 2026, growing at a CAGR of 6.8% during the forecast period.
Our personal care and cosmetics research lab offers the highest testing and analysis services; we are NABL Accredited Laboratories. Contact our cosmetics testing lab in India with any questions you may have, or visit our website at https://farelabs.com/services/testing/personal-care-cosmetics-research-lab.
According to the latest research report by IMARC Group, The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. More Info:- https://www.imarcgroup.com/point-of-care-molecular-diagnostics-market
The global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.
The global point-of-care diagnostics devices and equipment market size will grow from $28.47 billion in 2022 to $32.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%.
Point of Care (POC) Diagnostic Devices Market Size is estimated to reach $48.9 billion by 2027 and it is poised to grow at a CAGR of 6.2% over the forecast period of 2022-2027.
Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.
Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
A report on “2015-2019 Future Horizons and Growth Strategies in the German Hospital Hemostasis Diagnostic Testing Market: Supplier Shares and Country Forecasts” added by Research Beam Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-german-hospital-hemostasis-diagnostic-testing-supplier-shares-and-country-forecasts-market
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories.
The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.
Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.
Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.
Allied Market Research has recently published a report on the point of care diagnostics market, which is a comprehensive study of the entire industry for the period of 2014–2022.
The Global Point of Care (PoC) molecular diagnostics market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.
The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161
The Business Research Company’s Diabetes Care Devices Market By Segments (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors), By Applications, By Trends And By Regions – Global Forecast To 2022 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/33uCTn0
A latest research report “Home Health Care And Residential Nursing Care Services Global Market Report” proposed by The Business Research Company provides a market summary on Market Analysis, Size, Trends and Growth. Read Full Report @ http://bit.ly/2XMvmfM Get Free Sample Copy @ http://bit.ly/2PzMtyA
Urinalysis tests refer to the range of tests that are conducted by taking urine as a sample for detecting symptoms for various kinds of diseases. It is considered one of the major tests for identifying any symptoms for liver diseases, diabetics, and kidney diseases. Urinalysis test consists of three types of test including chemical evaluation, microscopic examination, and gross examination.
According to #TechSci Research report, Global Rapid Test Kit Market stood at USD23.44 billion in 2020 and expected to grow at steady CAGR of 8.14% by 2026. Gain More Insight: https://bit.ly/3vEVaM0 Get Sample Report: https://bit.ly/37y0udo Press Release: https://bit.ly/3rzXsfK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
STD testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 154347.8 million by 2027 growing at a CAGR of 7.35% in the above-mentioned forecast period. Increasing cases of gonorrhoea & chlamydia and rising public awareness about STD are the factors which will create new opportunities for the STD testing market in the forecast period of 2020 to 2027.
Hemoglobin testing is the procedure of carrying out diagnostic tests to detect the levels of hemoglobin in the patient’s blood. Hemoglobin tests are used broadly by doctors as a part of their routine check-ups or to analyze a serious medical condition in the patient.
The growing awareness among patients and healthcare providers towards the importance of early diagnosis of cardiovascular diseases (CVDs), dyspnea, hypertrophic cardiomyopathy, etc., is primarily driving the cardiopulmonary stress testing systems market. In line with this, the expanding geriatric population with decreased functional capacities is augmenting the adoption of CPST systems, which is further stimulating the market growth.
Age 55 and older & dependent children. Household income below ... Testing with earphones for tones, speech, and loudness levels. High technology testing appears ...